Cargando…
A Novel Vaccine Employing Non-Replicating Rabies Virus Expressing Chimeric SARS-CoV-2 Spike Protein Domains: Functional Inhibition of Viral/Nicotinic Acetylcholine Receptor Complexes
The emergence of the novel β-coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in a global pandemic of coronavirus disease 2019 (COVID-19). Clinical studies have documented that potentially severe neurological symptoms are associated with SARS-CoV-2 infection, t...
Autores principales: | Stefano, Michelle L., Kream, Richard M., Stefano, George B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278327/ https://www.ncbi.nlm.nih.gov/pubmed/32463026 http://dx.doi.org/10.12659/MSM.926016 |
Ejemplares similares
-
Is SARS-CoV-2 Spike glycoprotein impairing macrophage function via α7-nicotinic acetylcholine receptors?
por: Tanmay, Saraiya, et al.
Publicado: (2021) -
Simulations support the interaction of the SARS-CoV-2 spike protein with nicotinic acetylcholine receptors
por: Oliveira, A. Sofia F., et al.
Publicado: (2020) -
SARS-CoV-2 spike ectodomain targets α7 nicotinic acetylcholine receptors
por: O’Brien, Brittany C.V., et al.
Publicado: (2023) -
A potential interaction between the SARS-CoV-2 spike protein and nicotinic acetylcholine receptors
por: Oliveira, A. Sofia F., et al.
Publicado: (2021) -
Impact of SARS-CoV-2 spike protein on α7 nicotinic acetylcholine receptor in cells
por: Tillman, Tommy S., et al.
Publicado: (2022)